# Addentax Group Corp.: financial statements, quarterly

ATXG · Nasdaq · CIK 1650101 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/atxg.md) · [Financials](/companies/atxg/financials.md) · [Filings](/companies/atxg/filings.md) · [Insiders](/companies/atxg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/atxg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,335](/filings/0001493152-24-045272.md) | [1,468](/filings/0001493152-25-006558.md) | [1,297 d](/filings/0001641172-25-017050.md) | [851](/filings/0001641172-25-023677.md) | [1,113](/filings/0001493152-25-022485.md) | [865](/filings/0001493152-26-006571.md) | [1,630 d](/filings/0001493152-26-031055.md) | [826](/filings/0001493152-26-038442.md) | [821](/filings/0001493152-25-022485.md) | [976](/filings/0001493152-26-006571.md) | [2,748 d](/filings/0001493152-26-031055.md) | [3,438](/filings/0001493152-26-038442.md) |
| Cost of revenue | $k | [932](/filings/0001493152-24-045272.md) | [1,306](/filings/0001493152-25-006558.md) | [984 d](/filings/0001641172-25-017050.md) | [648](/filings/0001641172-25-023677.md) | [642](/filings/0001493152-25-022485.md) | [675](/filings/0001493152-26-006571.md) | [1,921 d](/filings/0001493152-26-031055.md) | [636](/filings/0001493152-26-038442.md) | [596](/filings/0001493152-25-022485.md) | [681](/filings/0001493152-26-006571.md) | [2,701 d](/filings/0001493152-26-031055.md) | [3,023](/filings/0001493152-26-038442.md) |
| Gross profit | $k | [403](/filings/0001493152-24-045272.md) | [162](/filings/0001493152-25-006558.md) | [313 d](/filings/0001641172-25-017050.md) | [203](/filings/0001641172-25-023677.md) | [471](/filings/0001493152-25-022485.md) | [190](/filings/0001493152-26-006571.md) | [(291) d](/filings/0001493152-26-031055.md) | [190](/filings/0001493152-26-038442.md) | [225](/filings/0001493152-25-022485.md) | [295](/filings/0001493152-26-006571.md) | [47.1 d](/filings/0001493152-26-031055.md) | [415](/filings/0001493152-26-038442.md) |
| Operating income | $k | [(305)](/filings/0001493152-24-045272.md) | [(450)](/filings/0001493152-25-006558.md) | [(116) d](/filings/0001641172-25-017050.md) | [(505)](/filings/0001641172-25-023677.md) | [(41.5)](/filings/0001493152-25-022485.md) | [(150)](/filings/0001493152-26-006571.md) | [(1,326) d](/filings/0001493152-26-031055.md) | [(355)](/filings/0001493152-26-038442.md) | [(450)](/filings/0001493152-25-022485.md) | [(68.8)](/filings/0001493152-26-006571.md) | [(656) d](/filings/0001493152-26-031055.md) | [(676)](/filings/0001493152-26-038442.md) |
| Interest expense | $k | [604](/filings/0001493152-24-045272.md) | [530](/filings/0001493152-25-006558.md) | [1,227 d](/filings/0001641172-25-017050.md) | [848](/filings/0001641172-25-023677.md) | [57.9](/filings/0001493152-25-022485.md) | [125](/filings/0001493152-26-006571.md) | [116 d](/filings/0001493152-26-031055.md) | [583](/filings/0001493152-26-038442.md) | [12.1](/filings/0001493152-25-022485.md) | [10.6](/filings/0001493152-26-006571.md) | [9.1 d](/filings/0001493152-26-031055.md) | [8.6](/filings/0001493152-26-038442.md) |
| Income tax | $k | [3.2](/filings/0001493152-24-045272.md) | [3.2](/filings/0001493152-25-006558.md) | [3.9 d](/filings/0001641172-25-017050.md) | [0.5](/filings/0001641172-25-023677.md) | [1.1](/filings/0001493152-25-022485.md) | [3.1](/filings/0001493152-26-006571.md) | [0.0 d](/filings/0001493152-26-031055.md) | [0.8](/filings/0001493152-26-038442.md) | [0.1](/filings/0001493152-25-022485.md) | [0.2](/filings/0001493152-26-006571.md) | [3.0 d](/filings/0001493152-26-031055.md) | [0.0](/filings/0001493152-26-038442.md) |
| Net income | $k | [1,362](/filings/0001493152-24-045272.md) | [(2,608)](/filings/0001493152-25-006558.md) | [865 d](/filings/0001641172-25-017050.md) | [(1,221)](/filings/0001641172-25-023677.md) | [(722)](/filings/0001493152-25-022485.md) | [(1,086)](/filings/0001493152-26-006571.md) | [(2,066) d](/filings/0001493152-26-031055.md) | [(392)](/filings/0001493152-26-038442.md) | [(103)](/filings/0001493152-25-022485.md) | [(4,196)](/filings/0001493152-26-006571.md) | [222 d](/filings/0001493152-26-031055.md) | [2,389](/filings/0001493152-26-038442.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001493152-24-045272.md) | [(0.66)](/filings/0001493152-25-006558.md) | not reported | [(0.25)](/filings/0001641172-25-023677.md) | [(0.13)](/filings/0001493152-24-045272.md) | [(0.19)](/filings/0001493152-25-006558.md) | not reported | [(0.06)](/filings/0001641172-25-023677.md) | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.37](/filings/0001493152-24-045272.md) | [(0.66)](/filings/0001493152-25-006558.md) | not reported | [(0.25)](/filings/0001641172-25-023677.md) | [(0.13)](/filings/0001493152-24-045272.md) | [(0.19)](/filings/0001493152-25-006558.md) | not reported | [(0.06)](/filings/0001641172-25-023677.md) | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.7](/filings/0001493152-23-040747.md) | [0.5](/filings/0001493152-24-006280.md) | [0.8](/filings/0001641172-25-017050.md) | [0.9](/filings/0001493152-24-032186.md) | [0.8](/filings/0001493152-24-045272.md) | [0.5](/filings/0001493152-25-006558.md) | [0.3](/filings/0001493152-26-031055.md) | [0.5](/filings/0001641172-25-023677.md) | [0.4](/filings/0001493152-25-022485.md) | [0.2](/filings/0001493152-26-006571.md) | [0.6](/filings/0001493152-26-038442.md) | [0.8](/filings/0001493152-26-038442.md) |
| Current assets | $m | [30.2](/filings/0001493152-23-040747.md) | [30.3](/filings/0001493152-24-006280.md) | [29.2](/filings/0001641172-25-017050.md) | [29.3](/filings/0001493152-24-032186.md) | [28.3](/filings/0001493152-24-045272.md) | [27.8](/filings/0001493152-25-006558.md) | [29.8](/filings/0001493152-26-031055.md) | [30.0](/filings/0001641172-25-023677.md) | [27.8](/filings/0001493152-25-022485.md) | [27.9](/filings/0001493152-26-006571.md) | [22.9](/filings/0001493152-26-038442.md) | [27.4](/filings/0001493152-26-038442.md) |
| Total assets | $m | [53.3](/filings/0001493152-23-040747.md) | [53.8](/filings/0001493152-24-006280.md) | [52.3](/filings/0001641172-25-017050.md) | [52.0](/filings/0001493152-24-032186.md) | [50.6](/filings/0001493152-24-045272.md) | [49.6](/filings/0001493152-25-006558.md) | [49.2](/filings/0001493152-26-031055.md) | [49.0](/filings/0001641172-25-023677.md) | [28.2](/filings/0001493152-25-022485.md) | [28.2](/filings/0001493152-26-006571.md) | [29.3](/filings/0001493152-26-038442.md) | [34.1](/filings/0001493152-26-038442.md) |
| Current liabilities | $m | [4.9](/filings/0001493152-23-040747.md) | [5.4](/filings/0001493152-24-006280.md) | [4.6](/filings/0001641172-25-017050.md) | [4.4](/filings/0001493152-24-032186.md) | [2.5](/filings/0001493152-24-045272.md) | [3.2](/filings/0001493152-25-006558.md) | [4.0](/filings/0001493152-26-031055.md) | [4.9](/filings/0001641172-25-023677.md) | [1.1](/filings/0001493152-25-022485.md) | [1.3](/filings/0001493152-26-006571.md) | [3.1](/filings/0001493152-26-038442.md) | [7.4](/filings/0001493152-26-038442.md) |
| Total liabilities | $m | [26.4](/filings/0001493152-23-040747.md) | [29.5](/filings/0001493152-24-006280.md) | [26.3](/filings/0001641172-25-017050.md) | [26.5](/filings/0001493152-24-032186.md) | [25.8](/filings/0001493152-24-045272.md) | [25.8](/filings/0001493152-25-006558.md) | [27.4](/filings/0001493152-26-031055.md) | [23.8](/filings/0001641172-25-023677.md) | [2.3](/filings/0001493152-25-022485.md) | [6.6](/filings/0001493152-26-006571.md) | [7.6](/filings/0001493152-26-038442.md) | [8.8](/filings/0001493152-26-038442.md) |
| Short-term borrowings | $m | [0.1](/filings/0001493152-23-040747.md) | [0.3](/filings/0001493152-24-006280.md) | [0.4](/filings/0001641172-25-017050.md) | [0.6](/filings/0001493152-24-032186.md) | [0.5](/filings/0001493152-24-045272.md) | [0.6](/filings/0001493152-25-006558.md) | [0.6](/filings/0001493152-26-031055.md) | [0.7](/filings/0001641172-25-023677.md) | [0.6](/filings/0001493152-25-022485.md) | [0.7](/filings/0001493152-26-006571.md) | [0.7](/filings/0001493152-26-038442.md) | [0.7](/filings/0001493152-26-038442.md) |
| Shareholders' equity | $m | [26.8](/filings/0001493152-25-006558.md) | [24.2](/filings/0001493152-25-006558.md) | [26.0](/filings/0001493152-26-006571.md) | [25.5](/filings/0001493152-25-022485.md) | [24.8](/filings/0001493152-26-006571.md) | [23.8](/filings/0001493152-26-006571.md) | [21.7](/filings/0001493152-26-031055.md) | [25.2](/filings/0001493152-25-022485.md) | [25.9](/filings/0001493152-26-006571.md) | [21.6](/filings/0001493152-26-006571.md) | [21.8](/filings/0001493152-26-038442.md) | [25.4](/filings/0001493152-26-038442.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(469) d](/filings/0001493152-24-045272.md) | [57.7 d](/filings/0001493152-25-006558.md) | [1,110 d](/filings/0001641172-25-017050.md) | [(193)](/filings/0001641172-25-023677.md) | [722 d](/filings/0001493152-25-022485.md) | [273 d](/filings/0001493152-26-006571.md) | [13.6 d](/filings/0001493152-26-031055.md) | [(458)](/filings/0001493152-26-038442.md) | [(509) d](/filings/0001493152-25-022485.md) | [(115) d](/filings/0001493152-26-006571.md) | [479 d](/filings/0001493152-26-031055.md) | [(24.4)](/filings/0001493152-26-038442.md) |
| Capital expenditure | $k | not reported | [130 d](/filings/0001493152-25-006558.md) | [0.1 d](/filings/0001641172-25-017050.md) | [27.4](/filings/0001641172-25-023677.md) | [80.1 d](/filings/0001493152-25-022485.md) | [38.1 d](/filings/0001493152-26-006571.md) | [52.1 d](/filings/0001493152-26-031055.md) | [77.9](/filings/0001493152-26-038442.md) | [38.6 d](/filings/0001493152-25-022485.md) | [32.8 d](/filings/0001493152-26-006571.md) | [31.6 d](/filings/0001493152-26-031055.md) | [0.8](/filings/0001493152-26-038442.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.7](/filings/0001493152-23-040747.md) | [28.4](/filings/0001493152-24-006280.md) | [3.3](/filings/0001493152-24-032186.md) | [3.7](/filings/0001493152-24-045272.md) | [4.0](/filings/0001493152-25-006558.md) | [4.8](/filings/0001641172-25-023677.md) | [5.4](/filings/0001493152-25-022485.md) | [5.8](/filings/0001493152-26-006571.md) | [0.4](/filings/0001493152-26-038442.md) | [7.9](/filings/0001493152-25-022485.md) | [9.3](/filings/0001493152-26-006571.md) | [0.8](/filings/0001493152-26-038442.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,177,974 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038442.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.